Ledipasvir/Sofosbuvir: A Review of Its Use in Chronic Hepatitis C

2015/04/01 by Gillian M. Keating · 17 citations
Medicine · #Cirrhosis #Gastroenterology #Hepacivirus #Hepatitis C #Hepatitis C virus #Hepatitis C virus research #Internal medicine #Ledipasvir #Liver Disease Diagnosis and Treatment #Liver Disease and Transplantation #Medicine #NS5A #Regimen #Ribavirin #Sofosbuvir #Virology #Virus

paper · doi:10.1007/s40265-015-0381-2

openalex publication_date 2015/04/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Cited by

• Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. [europepmc]
• The role of HCV proteins on treatment outcomes. [europepmc]
• Computational predictions suggest that structural similarity in viral polymerases may lead to comparable allosteric binding sites. [europepmc]
• Aeginetia indica Decoction Inhibits Hepatitis C Virus Life Cycle. [europepmc]
• Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor. [europepmc]
• Revisiting Orthopaedic Surgery Residents' Views of the CDC and AAOS Precautionary Guidelines for HIV. [europepmc]
• Association of Ledipasvir-Sofosbuvir Treatment With Uveitis in Patients Treated for Hepatitis C. [europepmc]
• Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant. [europepmc]
• Tumour Regression via Integrative Regulation of Neurological, Inflammatory, and Hypoxic Tumour Microenvironment. [europepmc]
• Improved Hepatitis C Cure Cascade Outcomes Among Urban Baby Boomers in the Direct-Acting Antiviral Era. [europepmc]
• Ages of hepatocellular carcinoma occurrence and life expectancy are associated with a UGT2B28 genomic variation. [europepmc]
• HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens. [europepmc]
• HCV genotypes and their determinative role in hepatitis C treatment. [europepmc]
• Inhibitory activity of limonoids from Khaya grandifoliola C.DC (Meliaceae) against hepatitis C virus infection in vitro . [europepmc]
• Prevalence and predictors of abnormal alanine aminotransferase in patients with HCV who have achieved SVR. [europepmc]
• A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs). [europepmc]
• Drug Repurposing of Approved Drugs Elbasvir, Ledipasvir, Paritaprevir, Velpatasvir, Antrafenine and Ergotamine for Combating COVID19 [europepmc]